Insider · CIK 0001609405
Khuong Chau Quang
Reports to the SEC for 10 companies · SAN DIEGO, CA
Transactions
50
Companies
10
Filings
13
CIK
0001609405
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-06-22 | NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-14 | Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award | — |
| 2023-06-14 | DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-11-11 | Fusion Pharmaceuticals Inc.A Award | +$100K |
| 2022-06-23 | NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-14 | Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-14 | DMRADamora Therapeutics, Inc. · /s/ Jonathan Freve, attorney-in-factA Award | — |
| 2021-11-17 | DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-24 | NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-04 | Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award | — |
| 2021-05-26 | DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-04-20 | SYBXSYNLOGIC, INC.A Award | +$5M |
| 2020-11-02 | DMRADamora Therapeutics, Inc.C Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc.C Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc.C Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc.P Purchase | +$7.86M |
| 2020-11-02 | DMRADamora Therapeutics, Inc.P Purchase | +$3.14M |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series C-2 Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series C-2 Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series C-4 Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series C-4 Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series C-5 Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series C-5 Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion | — |
| 2020-11-02 | DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion | — |
| 2020-10-09 | INSPInspire Medical Systems, Inc.A Award | +$11.8K |
| 2020-09-25 | DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award | −$4.02M |
| 2020-09-25 | DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award | −$1.61M |
| 2020-09-25 | DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award | −$2M |
| 2020-08-18 | INSPInspire Medical Systems, Inc.S Sale | −$4.73M |
| 2020-08-17 | INSPInspire Medical Systems, Inc.S Sale | −$10.2M |
| 2020-08-14 | INSPInspire Medical Systems, Inc.S Sale | −$2.21M |
| 2020-08-13 | INSPInspire Medical Systems, Inc.S Sale | −$3.22M |
| 2020-08-12 | INSPInspire Medical Systems, Inc.S Sale | −$4.59M |
| 2020-08-11 | INSPInspire Medical Systems, Inc.S Sale | −$4.22M |
| 2020-08-10 | INSPInspire Medical Systems, Inc.S Sale | −$5.02M |
| 2020-08-07 | INSPInspire Medical Systems, Inc.S Sale | −$3.08M |
| 2020-07-10 | INSPInspire Medical Systems, Inc.A Award | — |
| 2020-06-30 | Fusion Pharmaceuticals Inc.C Conversion | — |
| 2020-06-30 | Fusion Pharmaceuticals Inc.P Purchase | +$12M |
| 2020-06-30 | Fusion Pharmaceuticals Inc.P Purchase | +$3.27M |
| 2020-06-30 | Fusion Pharmaceuticals Inc.Class B Preferred SharesC Conversion | — |
| 2020-06-25 | Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award | — |
| 2020-06-11 | NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-06-04 | SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award | — |
| 2020-06-02 | Fusion Pharmaceuticals Inc.Class B Preferred SharesP Purchase | +$6.84M |
| 2020-04-30 | INSPInspire Medical Systems, Inc. · Stock Option (right to buy)A Award | — |
| 2020-04-10 | INSPInspire Medical Systems, Inc.A Award | — |
| 2020-03-06 | INSPInspire Medical Systems, Inc.S Sale | −$41.8M |
Recent filings
- 4Khuong Chau Quang0001140361-23-031192SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-23-037283SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-23-037093SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-22-056481SEC(opens sec.gov)
- 4Khuong Chau Quang0001567619-22-013368SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-22-038771SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-22-036933SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-21-065847SEC(opens sec.gov)
- 4Khuong Chau Quang0001567619-21-012666SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-21-038578SEC(opens sec.gov)
- 4Khuong Chau Quang0001209191-21-036509SEC(opens sec.gov)
- 4Khuong Chau Quang0000947871-21-000454SEC(opens sec.gov)
- 4Khuong Chau Quang0000899243-20-030411SEC(opens sec.gov)
Companies
- Damora Therapeutics, Inc.DirectorDMRA
- Fusion Pharmaceuticals Inc.Director
- Inspire Medical Systems, Inc.DirectorINSP
- Nabriva Therapeutics Legacy plcDirector, 10% Owner
- Nabriva Therapeutics plcDirector, 10% Owner
- NextCure, Inc.DirectorNXTC
- OTONOMY, INC.Director
- PALVELLA THERAPEUTICS, INC.Director, 10% OwnerPVLA
- SYNLOGIC, INC.DirectorSYBX
- Whitehawk Therapeutics, Inc.Director, 10% OwnerWHWK
Address
C/O OTONOMY, INC. 6275 NANCY RIDGE DRIVE
SAN DIEGO, CA, 92121